Event Details

Sep 16, 2016

Symposium 1: Early stage drug candidate strategies for LQT and Arrhythmia HTS screening

  • User Meeting
  • North America
  • Torrey Pines, San Diego, California USA
Hosted by Molecular Devices


Looming FDA Guidelines for hERG and Cardiac toxicity testing|(speaker TBD, pending review)
Beat rates and Beyond, Alexandre Colas, PhDSanford Burnham Prebys
New strategies for phenotypic screening of cardiomyocytes using high-speed High Content Imaging strategies to analyze beat rate for screening and elucidation of phenotypes
Graphene vs. Optogenetics|Elena Molokanova, NanoTools Bio
Optically stimulating cells without genetic modifications, an Imaging Approach
Rapid selection and development of GPCR expressing cell lines|Claudia Melara, Molecular Devices
HTS for hERG and cardiomyocyte testing|Peter Miu, Ph.D. Molecular Devices 
Using Potassium Ion Channels and automated Electrophysiology
hERG monitoring using low cost, high throughput assays for early stage candidate testing.
New High Content Screening Applications|Robert Damoiseaux, UCLA       
Locations and Dates:
Symposium 1
Torrey Pines, San Diego, CA USA
September 16, 2016
12:00 - 4:30 PM
Symposium 2
Westwood, Los Angeles, CA USA
September 22, 2016
11:00 - 4:00 PM